Literature DB >> 23675979

Hepatic failure in pregnancy successfully treated by online hemodiafiltration: Chronic hepatitis B virus infection without viral genome mutation.

Shinju Arata1, Akito Nozaki, Kenichi Takizawa, Masaaki Kondo, Manabu Morimoto, Kazushi Numata, Sanae Hayashi, Tsunamasa Watanabe, Yasuhito Tanaka, Katsuaki Tanaka.   

Abstract

A 23-year-old nulliparous woman, a hepatitis B virus (HBV) carrier with stable liver functions, presented with exacerbation of viral replication (HBV DNA level >9.0 log copies/mL) in gestational week 26. During the subsequent follow up without antiviral therapy, she was hospitalized with progression to hepatic failure in gestational week 35. Following initiation of antiviral therapy with lamivudine, emergent cesarean delivery was conducted for fetal safety. Liver atrophy and persistent hepatic encephalopathy (stage 2) necessitated artificial liver support (ALS) involving online hemodiafiltration (HDF) and plasma exchange. She regained full consciousness after the sixth online HDF session. ALS was terminated after the seventh online HDF session. On day 33 of hospitalization, she was discharged home without sequelae. Genetic analysis of the HBV strain isolated from her serum showed that this strain had genotype C. Direct full-length sequencing identified no known mutations associated with fulminant hepatitis B. HBV-related hepatic failure observed in the present case might have been related to perinatal changes in the host immune response.
© 2013 The Japan Society of Hepatology.

Entities:  

Keywords:  artificial liver support; blood purification therapy; flare; fulminant hepatitis; viral mutation

Year:  2013        PMID: 23675979     DOI: 10.1111/hepr.12090

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  1 in total

1.  The Administration of Tenofovir Disoproxil Fumarate for Pregnant Japanese Women with Chronic Hepatitis B.

Authors:  Maito Suoh; Akihiro Tamori; Yuga Amano-Teranishi; Takashi Nakai; Masaru Enomoto; Yasuko Kawasaki; Kiyohide Kioka; Norifumi Kawada
Journal:  Intern Med       Date:  2020-01-15       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.